|Bid||6.90 x 3000|
|Ask||8.00 x 1200|
|Day's range||7.19 - 7.63|
|52-week range||4.97 - 16.26|
|Beta (5Y monthly)||0.88|
|PE ratio (TTM)||15.72|
|Earnings date||27 Jul 2022 - 01 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||05 Jan 2022|
|1y target est||17.19|
Zynex Inc. (ZYXI) delivered earnings and revenue surprises of -40% and 0.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 21.05% and 1.69%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
My name is Thomas Sandgaard, President and CEO of Zynex. Today, we will be covering activities in both of our divisions at Zynex Medical, where we focus on pain management and Zynex Monitoring Solutions.